Expression of PD-L1 and IDO in hormone receptor negative DCIS.

e14116Background: Although outcomes from ductal carcinoma in situ (DCIS) are generally excellent, hormone receptor (HR) negative DCIS is associated with a higher rate of recurrence. There is no che...